F. HoffmannLa Roche Ltd ROG Financial and Strategic SWOT Analysis Review [Report Updated: 26092017] Prices from USD $125
F. HoffmannLa Roche Ltd ROG Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.
Highlights
F. HoffmannLa Roche Ltd Roche develops drugs that improve the standard of care across major disease areas. It provides pharmaceuticals in cancer, neuroscience, infection, immunology, ophthalmology, cardiovascular and metabolism, immunology, hematology, hemophilia and respiratory disease areas. The company also provides in vitro diagnostics, tissuebased cancer diagnostics, as well as diabetes management solutions. Roche's diagnostic products include clinical chemistry and immunoassays, molecular diagnostics, tissue diagnostics, point of care diagnostics, laboratory automation and IT solutions, urinalysis products, lab testing products, custom biotech solutions, patient selftesting products and solutions for life science. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. Roche is headquartered in Basel, Switzerland.
F. HoffmannLa Roche Ltd Key Recent Developments
Sep 08,2017: Roche announces progress in biomarker science in cancer immunotherapy at the European Society for Medical Oncology Congress
Sep 07,2017: Roche ranked again the most sustainable healthcare company in the Dow Jones Sustainability Indices
Aug 31,2017: Roche to present new data from its oncology portfolio at the 2017 European Society for Medical Oncology Congress
Jul 31,2017: Roche to showcase power of connected lab at AACC 2017 Clinical Lab Expo
Jul 27,2017: Roche reports strong performance in the first half of 2017
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Original Article: F. HoffmannLa Roche Ltd ROG Financial and Strategic SWOT Analysis Review [Report Updated: 26092017] Prices from USD $125
